BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 17016230)

  • 1. Does celecoxib have an adverse effect on bone remodeling and ingrowth in humans?
    Hofmann AA; Bloebaum RD; Koller KE; Lahav A
    Clin Orthop Relat Res; 2006 Nov; 452():200-4. PubMed ID: 17016230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of celecoxib on blood loss, pain, and recovery of function after total knee replacement: a randomized placebo-controlled trial.
    Meunier A; Lisander B; Good L
    Acta Orthop; 2007 Oct; 78(5):661-7. PubMed ID: 17966026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective randomized trial on the role of perioperative celecoxib administration for total knee arthroplasty: improving clinical outcomes.
    Reuben SS; Buvenandran A; Katz B; Kroin JS
    Anesth Analg; 2008 Apr; 106(4):1258-64, table of contents. PubMed ID: 18349203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mineral apposition rates of human cancellous bone at the interface of porous coated implants.
    Bloebaum RD; Bachus KN; Momberger NG; Hofmann AA
    J Biomed Mater Res; 1994 May; 28(5):537-44. PubMed ID: 8027094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Celecoxib in the treatment of primary dysmenorrhea: results from two randomized, double-blind, active- and placebo-controlled, crossover studies.
    Daniels S; Robbins J; West CR; Nemeth MA
    Clin Ther; 2009 Jun; 31(6):1192-208. PubMed ID: 19695387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, multicentre, double-blind, parallel-group study to assess the adverse event-related discontinuation rate with celecoxib and diclofenac in elderly patients with osteoarthritis.
    Dahlberg LE; Holme I; Høye K; Ringertz B
    Scand J Rheumatol; 2009; 38(2):133-43. PubMed ID: 19165648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effectiveness and tolerability of lidocaine patch 5% versus celecoxib for osteoarthritis-related knee pain: post hoc analysis of a 12 week, prospective, randomized, active-controlled, open-label, parallel-group trial in adults.
    Kivitz A; Fairfax M; Sheldon EA; Xiang Q; Jones BA; Gammaitoni AR; Gould EM
    Clin Ther; 2008 Dec; 30(12):2366-77. PubMed ID: 19167595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Celecoxib does not appear to affect prosthesis fixation in total knee replacement: A randomized study using radiostereometry in 50 patients.
    Meunier A; Aspenberg P; Good L
    Acta Orthop; 2009 Feb; 80(1):46-50. PubMed ID: 19234885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determining relevance of a weight-bearing ovine model for bone ingrowth assessment.
    Willie BM; Bloebaum RD; Bireley WR; Bachus KN; Hofmann AA
    J Biomed Mater Res A; 2004 Jun; 69(3):567-76. PubMed ID: 15127404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analgesic efficacy of celecoxib in postoperative oral surgery pain: a single-dose, two-center, randomized, double-blind, active- and placebo-controlled study.
    Cheung R; Krishnaswami S; Kowalski K
    Clin Ther; 2007; 29 Suppl():2498-510. PubMed ID: 18164917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of cardiovascular events in patients receiving celecoxib: a meta-analysis of randomized clinical trials.
    White WB; West CR; Borer JS; Gorelick PB; Lavange L; Pan SX; Weiner E; Verburg KM
    Am J Cardiol; 2007 Jan; 99(1):91-8. PubMed ID: 17196469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial of a 6-week course of celecoxib on proteinuria in diabetic kidney disease.
    Sinsakul M; Sika M; Rodby R; Middleton J; Shyr Y; Chen H; Han E; Lehrich R; Clyne S; Schulman G; Harris R; Lewis J
    Am J Kidney Dis; 2007 Dec; 50(6):946-51. PubMed ID: 18037095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of two different dosages of celecoxib with diclofenac for the treatment of active ankylosing spondylitis: results of a 12-week randomised, double-blind, controlled study.
    Sieper J; Klopsch T; Richter M; Kapelle A; Rudwaleit M; Schwank S; Regourd E; May M
    Ann Rheum Dis; 2008 Mar; 67(3):323-9. PubMed ID: 17616556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study.
    Nery FG; Monkul ES; Hatch JP; Fonseca M; Zunta-Soares GB; Frey BN; Bowden CL; Soares JC
    Hum Psychopharmacol; 2008 Mar; 23(2):87-94. PubMed ID: 18172906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obturator versus femoral nerve block for analgesia after total knee arthroplasty.
    Kardash K; Hickey D; Tessler MJ; Payne S; Zukor D; Velly AM
    Anesth Analg; 2007 Sep; 105(3):853-8. PubMed ID: 17717250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hepatic safety and tolerability of the cyclooxygenase-2 selective NSAID celecoxib: pooled analysis of 41 randomized controlled trials.
    Soni P; Shell B; Cawkwell G; Li C; Ma H
    Curr Med Res Opin; 2009 Aug; 25(8):1841-51. PubMed ID: 19530981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular events associated with the use of four nonselective NSAIDs (etodolac, nabumetone, ibuprofen, or naproxen) versus a cyclooxygenase-2 inhibitor (celecoxib): a population-based analysis in Taiwanese adults.
    Huang WF; Hsiao FY; Wen YW; Tsai YW
    Clin Ther; 2006 Nov; 28(11):1827-36. PubMed ID: 17213003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New diagnosis of hypertension among celecoxib and nonselective NSAID users: a population-based cohort study.
    Wang J; Mullins CD; Mamdani M; Rublee DA; Shaya FT
    Ann Pharmacother; 2007 Jun; 41(6):937-43. PubMed ID: 17488830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenase-2 inhibition increases mortality, enhances left ventricular remodeling, and impairs systolic function after myocardial infarction in the pig.
    Timmers L; Sluijter JP; Verlaan CW; Steendijk P; Cramer MJ; Emons M; Strijder C; Gründeman PF; Sze SK; Hua L; Piek JJ; Borst C; Pasterkamp G; de Kleijn DP
    Circulation; 2007 Jan; 115(3):326-32. PubMed ID: 17210840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Celecoxib plus aspirin versus naproxen and lansoprazole plus aspirin: a randomized, double-blind, endoscopic trial.
    Goldstein JL; Cryer B; Amer F; Hunt B
    Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1167-74. PubMed ID: 17916545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.